MedTrace Logo

Circulating Micro RNAs Expression in Egyptian Bronchial Asthma and COPD Patients

NCT02719145 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-04-25

No results posted yet for this study

Summary

This cross sectional study will be carried out on 30 subjects who will be recruited from the outpatient clinic of Chest Department, Tanta University Hospital.

They will be classified into 3 groups:

Group I: It will include 10 healthy volunteer subjects. Group II: It will include 10 asthmatic patients. Group III: It will include 10 COPD patients. miR-7, miR-20a, miR-21, miR-22, miR-145 and miR-155 will be measured in serum samples from all subjects

Conditions

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Adel S Bediwy, MD · Chest Department, Faculty of Medicine, Tanta University

  • Salwa A Ganna, MD · Chest Department, Faculty of Medicine, Tanta University

  • Said Hammad, MD · Clinical Pathology Department, Faculty of Medicine, Tanta University

  • Abdel-Aziz A Zidan, PHD · Director of Genomics and Proteomics Unit, Center of Excellence in Cancer Research, Tanta University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-06-30
Completion
2016-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02719145 on ClinicalTrials.gov